FindTrial
Sign In

Study on the expression levels of serum angiopoietin, syndecan-1, procalcitonin, and C-reactive protein in predicting the 30 day all-cause mortality rate of sepsis patients

Study on the expression levels of serum angiopoietin, syndecan-1, procalcitonin, and C-reactive protein in predicting the 30 day all-cause mortality rate of sepsis patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100044
Enrollment
Unknown
Registered
2025-04-02
Start date
2024-06-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

sepsis group:none

Sponsors

Beijing Chaoyang Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult patients residing in the ICU, aged over 18 years old; 2. Meets Sepsis 3.0 diagnostic criteria; 3.Obtain informed consent form.

Exclusion criteria

Exclusion criteria: 1. Diagnosis of sepsis upon entry for more than 24 hours; 2. Patients expected to die within 48 hours; 3. Dying state

Design outcomes

Primary

MeasureTime frame
30 day all-cause mortality rate after diagnosis of sepsis;—

Secondary

MeasureTime frame
The incidence of AKI and RRT demand within 7 days after diagnosis of sepsis;No mechanical ventilation time within 30 days;—

Countries

China

Contacts

Public ContactWenxiong Li

Beijing Chaoyang Hospital Affiliated to Capital Medical University

liwx1126@163.com+86 136 0109 7813

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026